Hangzhou Diagens Biotechnology Co., Ltd.

杭州德适生物科技股份有限公司

02526.HK

Develops medical imaging products and services in China, including AI-assisted chromosome karyotyping diagnostic software, medical imaging devices, reagents and consumables, and technology licensing, serving prenatal diagnosis and assisted reproduction fields.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Distribution model
• Single product, business line or region
• Outsourced production (OEM / contract manufacturing)
• Business changes and acquisitions
• Losses and path to profitability
• Cash burn and runway
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Investments and fair-value assets
• Adverse change after the track record
• Non-recurring gains and losses
• Related-party transactions and balances
• Chapter 18A biotech